Policy 84: Multilingualism on the EMA website and in external communications
Submitted by Anonymous (not verified) on 2 June 2026 - 13:20
Policy 84: Multilingualism on the EMA website and in external communications
EMEA-001134-PIP01-11
Submitted by Anonymous (not verified) on 2 June 2026 - 12:54
EMEA-001134-PIP01-11
PSUSA/00001263/202507
Submitted by Anonymous (not verified) on 2 June 2026 - 12:18
PSUSA/00001263/202507
Data protection notice for legal entity and bank account validation regarding payments
Submitted by Anonymous (not verified) on 2 June 2026 - 11:00
Data protection notice for legal entity and bank account validation regarding payments
Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)
Submitted by Anonymous (not verified) on 2 June 2026 - 10:46
Meeting summaries of the Immunisation and Vaccine Monitoring Advisory Board (IVMAB)
Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published
Submitted by Anonymous (not verified) on 1 June 2026 - 16:15
Herbal medicinal product: Lecithinum ex soya, Glycine max (L.) Merr., P: Draft published
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 16:00
Human medicines European public assessment report (EPAR): Emadine, emedastine, Date of authorisation: 27/01/1999, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 15:32
Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Date of authorisation: 29/05/2026, Status: Authorised
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 24, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 15:00
Human medicines European public assessment report (EPAR): Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan), lopinavir,ritonavir, Date of authorisation: 14/01/2016, Revision: 24, Status: Authorised
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 1 June 2026 - 14:00
Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 7, Status: Authorised